However, we found significantly altered p-AKT levels in response to the overexpression or suppression of TSP50 in breast cancer cells, with constant AKT levels, indicating that PI3K/AKT signaling is stimulated by TSP50 (Fig. 7A and B, Fig. S5G and H). The gene discussed is PRSS50; the disease is breast carcinoma.